Meridian Bioscience Strengthens Leadership with Andy Kitzmiller as CEO

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced executive appointments aimed at strengthening global operations and accelerating strategic growth across Diagnostics and Life Science.

Andy Kitzmiller Appointed President and Chief Executive Officer

Andy Kitzmiller has been promoted to President and Chief Executive Officer, effective immediately. 

"Andy's leadership, financial discipline, and collaborative approach have been pivotal in driving Meridian's performance and integration across our Diagnostics and Life Science businesses," said Dr. Young-Shik Cho, Founder and Chairman of SD Biosensor, Meridian's majority shareholder.  "He is the right leader to guide Meridian into its next chapter, advancing our innovation vision, deepening our global partnerships, and delivering sustainable growth," added Tom Kichler, Chairman of the Board.